[HTML][HTML] How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia
L Alphs, N Schooler, J Lauriello - Schizophrenia research, 2014 - Elsevier
This article reviews key methodological considerations for clinical trials that utilize
explanatory and pragmatic trial designs and relates these contrasting approaches to the …
explanatory and pragmatic trial designs and relates these contrasting approaches to the …
Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression
I Turkoz, L Alphs, J Singh, C Jamieson… - Acta Psychiatrica …, 2021 - Wiley Online Library
Abstract Objective To use the Clinical Global Impression‐Severity (CGI‐S) scale to estimate
clinically meaningful and clinically substantial changes as measured using the Montgomery …
clinically meaningful and clinically substantial changes as measured using the Montgomery …
Prevalence of suicide attempts and correlates among first-episode and untreated major depressive disorder patients with comorbid dyslipidemia of different ages of …
Y Jiang, Y Lu, Y Cai, C Liu, XY Zhang - BMC psychiatry, 2023 - Springer
Background Patients with dyslipidemia are at increased risk for suicide, especially those
with major depressive disorder (MDD). Few studies have investigated the independent …
with major depressive disorder (MDD). Few studies have investigated the independent …
Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS
MT Samara, RR Engel, A Millier, J Kandenwein… - European …, 2014 - Elsevier
Abstract The Global Assessment of Functioning (GAF) and the Social and Occupational
Functioning Assessment Scale (SOFAS) are rating scales commonly used to assess the …
Functioning Assessment Scale (SOFAS) are rating scales commonly used to assess the …
Paliperidone for the treatment of schizoaffective disorder
L Alphs, DJ Fu, I Turkoz - Expert opinion on pharmacotherapy, 2016 - Taylor & Francis
Introduction: Schizoaffective disorder (SCA) is a complex mental illness characterized by
psychosis and affective symptoms. Treatment usually involves concomitant therapy with …
psychosis and affective symptoms. Treatment usually involves concomitant therapy with …
[HTML][HTML] Cortical thickness and surface area abnormalities in bipolar I and II disorders
Objective Although bipolar II disorder (BD II) is not simply a mitigated form of bipolar I
disorder (BD I), their neurobiological differences have not been elucidated. The present …
disorder (BD I), their neurobiological differences have not been elucidated. The present …
Psychometric properties of the young mania rating scale as a mania severity measure in patients with bipolar I disorder
Z Mohammadi, A Pourshahbaz… - Practice in Clinical …, 2018 - jpcp.uswr.ac.ir
Methods: This cross-sectional study included 65 patients with bipolar I disorder in the manic
phase and 145 healthy individuals. The patients were selected from the Razi Psychiatric …
phase and 145 healthy individuals. The patients were selected from the Razi Psychiatric …
Gender differences in risk factors for suicide attempts among young, first-episode and drug-naive major depressive disorder patients with anxiety symptoms
Background Suicide attempts and anxiety are common commodities in patients with major
depressive disorder (MDD), and suicide attempts are often associated with anxiety …
depressive disorder (MDD), and suicide attempts are often associated with anxiety …
Responsiveness of the personal and social performance scale in patients with schizophrenia
The responsiveness (ability to detect change) of the Personal and Social Performance scale
(PSP) is largely unknown, limiting its use as an outcome measure. The purpose of this study …
(PSP) is largely unknown, limiting its use as an outcome measure. The purpose of this study …
Paliperidone palmitate once-monthly injectable treatment for acute exacerbations of schizoaffective disorder
DJ Fu, I Turkoz, RB Simonson, D Walling… - Journal of clinical …, 2016 - journals.lww.com
The optimal treatment for schizoaffective disorder (SCA) is not well established. In this initial
6-month open-label treatment period of a large, multiphase, relapse-prevention study, the …
6-month open-label treatment period of a large, multiphase, relapse-prevention study, the …